Tumoral epileptogenicity: How does it happen'

Epilepsia

Volumn 54, Issue SUPPL. 9, 2013, Pages 30-34

  Pallud, Johan ^a,b   Capelle, Laurent ^c   Huberfeld, Gilles ^c,d  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

Chloride; Epilepsy; GABA; Glioma; Glutamate

Indexed keywords

4 AMINOBUTYRIC ACID; CHLORIDE; GLUTAMIC ACID;

BRAIN; BRAIN TUMOR; EPILEPSY; GLIOMA; HUMAN; PATHOLOGY; REVIEW; COMPLICATION;

CHLORIDE; EPILEPSY; GABA; GLIOMA; GLUTAMATE;

BRAIN; BRAIN NEOPLASMS; EPILEPSY; GLIOMA; HUMANS;

EID: 84894378413     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12440     Document Type: Article

References (25)

1. Aronica E, Boer K, Redeker S, Spliet WG, Van Rijen PC, Troost D, Gorter JA. (2007) Differential expression patterns of chloride transporters, Na+-K+-2Cl-cotransporter and K+-Cl-cotransporter, in epilepsy-associated malformations of cortical development. Neuroscience 145:185-196.
2. Beaumont A, Whittle IR. (2000) The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 142:1-15.
3. Bianchi L, De Micheli E, Bricolo A, Ballini C, Fattori M, Venturi C, Pedata F, Tipton KF, Della Corte L. (2004) Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study. Neurochem Res 29:325-334.
4. Buckingham SC, Robel S. (2013) Glutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environment. Neurochem Int In press.
5. Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H. (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17:1269-1274.
6. Conti L, Palma E, Roseti C, Lauro C, Cipriani R, de Groot M, Aronica E, Limatola C. (2011) Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Epilepsia 52:1635-1644.
7. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M,Inoue K, Gravel C, Salter MW, De Koninck Y. (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017-1021.
8. de Groot J, Sontheimer H. (2011) Glutamate and the biology of gliomas. Glia 59:1181-1189.
9. de Groot M, Iyer A, Zurolo E, Anink J, Heimans JJ, Boison D, Reijneveld JC, Aronica E. (2012a) Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumorassociated epilepsy. Epilepsia 53:58-66.
10. de Groot M, Reijneveld JC, Aronica E, Heimans JJ. (2012b) Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain 135:1002-1016.
11. Ernest NJ, Weaver AK, Van Duyn LB, Sontheimer HW. (2005) Relative contribution of chloride channels and transporters to regulatory volume decrease in human glioma cells. Am J Physiol Cell Physiol 288:C1451-C1460.
12. Haas BR, Sontheimer H. (2010) Inhibition of the sodium-potassiumchloride cotransporter isoform-1 reduces glioma invasion. Cancer Res 70:5597-5606.
13. Habela CW, Ernest NJ, Swindall AF, Sontheimer H. (2009) Chloride accumulation drives volume dynamics underlying cell proliferation and migration. J Neurophysiol 101:750-757.
14. Haglund MM, Berger MS, Kunkel DD, Franck JE, Ghatan S, Ojemann GA. (1992) Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg 77:209-216.
15. Hirsch JF, Buisson-Ferey J, Sachs M, Hirsch JC, Scherrer J. (1966) Electrocorticogram and unitary activites with expanding lesions in man. Electroencephalogr Clin Neurophysiol 21:417-428.
16. Huberfeld G, Wittner L, Clemenceau S, Baulac M, Kaila K, Miles R, Rivera C. (2007) Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J Neurosci 27:9866-9873.
17. Kohling R, Senner V, Paulus W, Speckmann EJ. (2006) Epileptiform activity preferentially arises outside tumor invasion zone in glioma xenotransplants. Neurobiol Dis 22:64-75.
18. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H. (2007) Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 67:9463-9471.
19. Marco P, Sola RG, Ramon y Cajal S, DeFelipe J. (1997) Loss of inhibitory synapses on the soma and axon initial segment of pyramidal cells in human epileptic peritumoural neocortex: implications for epilepsy. Brain Res Bull 44:47-66.
20. Olsen ML, Sontheimer H. (2008) Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiation. J Neurochem 107:589-601.
21. Savaskan NE, Heckel A, Hahnen E, Engelhorn T, Doerfler A, Ganslandt O, Nimsky C, Buchfelder M, Eyüpoglu I.Y. (2008) Small interfering RNA-mediated ×CT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med 14:629-632.
22. Shamji MF, Fric-Shamji EC, Benoit BG. (2009) Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev 32:275-284; discussion 84-6.
23. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M. (2001) Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010-1015.
24. van Breemen MS, Wilms EB, Vecht CJ. (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421-430.
25. Yuen TI, Morokoff AP, Bjorksten A, D'Abaco G, Paradiso L, Finch S, Wong D, Reid CA, Powell KL, Drummond KJ, Rosenthal MA, Kaye AH, O'Brien TJ. (2012) Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology 79:883-889.